The number of microbial threats -in the form of newly identified pathogens, infections crossing the species barrier to people, diseases adapting to new environments, transmissible drug-resistance genes and microbial agents appearing in more virulent forms -has multiplied to an unprecedented degree. The epidemiology of well-known infectious diseases has also been changing due to the globalisation of trade and in response to immunisation campaigns. This evolving epidemiology presents new challenges to countries' healthcare systems, in terms of both understanding and monitoring of determinants of infections, as well as in terms of service provision and the implementation of appropriate prevention measures. In this article we discuss the concepts of early warning systems and genome sequencing for public health laboratory surveillance and outbreak detection and response. The added value of these new means of surveillance can be seen when clinical and public health laboratory data is harmonised, aggregated and shared.
The number of microbial threats -in the form of newly identified pathogens, infections crossing the species barrier to people, diseases adapting to new environments, transmissible drug-resistance genes and microbial agents appearing in more virulent forms -has multiplied to an unprecedented degree. The epidemiology of well-known infectious diseases has also been changing due to the globalisation of trade and in response to immunisation campaigns. This evolving epidemiology presents new challenges to countries' healthcare systems, in terms of both understanding and monitoring of determinants of infections, as well as in terms of service provision and the implementation of appropriate prevention measures. In this article we discuss the concepts of early warning systems and genome sequencing for public health laboratory surveillance and outbreak detection and response. The added value of these new means of surveillance can be seen when clinical and public health laboratory data is harmonised, aggregated and shared.
Why early warning system are needed
Evidence suggests that traditional surveillance systems are vulnerable to the incomplete and delayed reporting of public health threats, highlighted by recent outbreaks. Many outbreaks have been characterised by delayed recognition and/or public health response.
Such delays diminish the window of opportunity to mount effective response measures and are likely to be costly to society 1 . For example, it was estimated that a one-week delay in the implementation of control measures for SARS in Canada resulted in a 2.6-fold increase in the mean epidemic size and a four-week extension of the mean epidemic duration 2 . In addition, the rapid identification of outbreaks and the implementation of control measures have been crucial in limiting the impact of epidemics, both in preventing more casualties and in shortening the period during which the stringent control measures were needed 3, 4 . Not surprisingly, researchers' attention has been directed to the development and evaluation of early warning systems. The aspirational goal of these systems is to improve the timeliness and accuracy of biothreat detection using traditional and new sources of surveillance data. In contrast to historical passive surveillance instruments, early warning systems have capacity for the active monitoring of historical data and provide automated alerts when aberrations in disease trends are identified.
Prospective detection of communicable disease outbreaks
Public health professionals have been very good at identifying highly focal outbreaks where the majority of clinical cases occur in spatially and temporally tight clusters. Sophisticated surveillance and early warning systems are not needed to detect these outbreaks, as they stand out dramatically from the background of sporadic cases. Of course, outbreaks come in many shapes and sizes, and when clinical cases of infection are less concentrated in space or time, or have lower attack rates, they are less visible and harder to detect. Our public health colleagues expect that laboratory based surveillance systems could assist in the identification of these events.
The identification, control and prevention of outbreaks relies on interacting local, regional and national healthcare structures with complimentary roles. They collect and generate different types of data in relation to public health surveillance. It appears that prospective laboratory based surveillance offers the most specific surveillance signals. There is increasing evidence demonstrating the value of rapid molecular profiling as a means of assisting outbreak detection in hospital settings 5, 6 . This can be of particular importance as the monitoring of mobile genetic elements, which spread antibiotic resistance genes, has become essential for successful infection control. In one prospective study, automated clonal The increasing complexity of bacterial typing methods and the interpretation of their results demand close collaborations between microbiologists and epidemiologists to ensure that alerts generated by early warning systems are sufficiently specific and sensitive and correspond well to epidemiological clusters. These collaborations are fostered through multidisciplinary networks. Such networks for subtype-based surveillance are being developed and adopted around the world for an increasing number of pathogens. The Enternet system, coordinated out of the European Centre for Disease Prevention and Control, provides surveillance and early warning across the EU member states. The PulseNet model has been deployed in the USA and Canada for many years, and a memorandum of understanding permits each country to consult the other's database of PFGE patterns. PulseNet International, with regional grouping for Latin America, Asia/Pacific, the Middle East and Europe, is now routinely exchanging patterns and information among a growing group of countries, paving the way toward a truly global network for subtype-based surveillance 8 . In parallel, the networks of national field epidemiology programs strive to develop uniform and collaborative investigative methods to match the growing laboratory capacity in prospective high-resolution subtyping. In Australia, a combined program for active surveillance and collaborative investigation, called OzFoodNet, now includes all of the states 9 . The appealing assumption is that new ways of networking and data sharing could enable the aggregation of clinical and public health data to support both clinical care and disease surveillance 10 .
Australian Biosecurity Intelligence Network (ABIN)
eResearch tools and open-source software for data mining and visualisation are gaining recognition and popularity among biomedical scientists. The Australian Pathogen Intelligence Community Space (APICS) (https://www.abin.org.au) aims to improve infectious disease surveillance by providing a secure online environment for collaborative research and the sharing of data, knowledge and resources between specialist pathology and microbiology providers, epidemiologists, public health professionals and multidisciplinary research teams. APICS developed data management and analysis tools for the secure uploading, trend/cluster analysis, and spatial/temporal visualisation of infectious disease data. Disease modules were built by integrating diverse pathogen information, including molecular and phenotypic subtyping and profiling information and de-identified clinical and geo-demographic patient data. Functionality was also created to incorporate external population and socioeconomic information from the Australian Bureau of Statistics. Three test disease modules were used to evaluate the utility of APICS. These modules were based on Mycobacterium tuberculosis genotyping and antibiotic resistance data, serotyping and antibiotic resistance monitoring of Streptococcus pneumoniae isolates associated with invasive pneumococcal disease and influenza sub-typing and antiviral resistance data. Output from these modules demonstrated the potential of APICS analytical and visualisation tools to link infectious disease cases with specific pathogen profiles, to distinguish epidemic strains from sporadic or emerging variants and to monitor spatio-temporal changes in pathogen subtypes and resistance profiles. Figure 1 shows an overview of the APICS application structure and an APICS-generated map depicting the spatial clustering of pathogens isolated from patients residing in different postcodes across the eastern states of Australia. Wide-scale adoption of APICS has the potential to create data sharing and analysis networks for the prospective monitoring of pathogen transmission and changes in pathogen/disease patterns. Network information could also be used to pinpoint key areas for future infectious disease research and optimise disease prevention/intervention strategies.
Genomics enhanced public health laboratory surveillance
Recent advances in DNA sequencing technology have made wholegenome sequencing (WGS) of pathogens of public health significance, within a clinically relevant turn-around-time, both technically and economically feasible. DNA sequencing offers important advantages over other methods of pathogen characterisation. It provides a universal solution with high throughput, speed and quality.
Sequencing is a standardised process regardless of the nature of microorganisms, and different species of pathogens could be processed simultaneously in a single sequencing run. This means that WGS could allow economies of scale at local or regional laboratories. Furthermore, a single WGS can often replace several traditional tests that reference laboratories will perform on a single isolate, while providing equivalent or superior-quality information. DNA sequences also represent an indisputable and possibly 'futureproof' data format amenable to exchange between jurisdictional laboratories and to comparison at the national and international
Under the Microscope levels. Finally, the potential utility of WGS for public health has been supported by the rapid growth of public databases with reference genomes. this time, as the WGS technology is still maturing and its costeffectiveness for public health surveillance and laboratory workflow requires further assessment. The main added value of genomicsenabled surveillance appears to be in the improved accuracy of case clustering. Furthermore, WGS offers an unprecedented level of resolution for distinguishing the degrees of relatedness amongst bacterial isolates and compliments existing epidemiological tools by providing a means to reconstruct recent chains of transmission, identify sequential acquisition of strains and detect cryptic outbreaks that might otherwise go unnoticed. WGS is also effective at determining whether isolates within a potential cluster are unrelated, thereby saving time and resources on outbreak investigations.
New analytics for public health laboratory surveillance and early warning
The plummeting cost of sequencing has led to a radical shift in the bioscience capacity bottleneck from the generation of data to its analysis. The linkage of structured genomic data with the unstructured information captured in scientific literature has emerged as one of the most appealing domains for the 'new analytics'. Genomic databases have grown exponentially and peer-reviewed publications made available through NCBI PubMed have grown at the rate of >4.8%, or more than two thousand new entries per day. Clearly the increased quantity of scientific and public health information is reaching the point where it cannot be sustained by current analytical practices. We argue that one possible solution could be software robots or 'bots' 26 . They have proven their effectiveness in accessing resources across the Internet and analysing the results to gain knowledge, which is then applied to fulfil specific tasks. Recent ground-breaking projects such as RoboEarthÓ (www.roboearth. [27] [28] [29] [30] .
Conclusions
Robust and flexible surveillance methods, standardised and rapid pathogen subtyping networks, and collaborative epidemiological investigation strategies will be the marks of a successful approach to controlling communicable infections in the coming years. The development of the 'smart analytics' will transform the use of WGS for public health surveillance at regional, national and global levels. In particular, the simultaneous consideration of synergistic and dynamically evolving lines of evidence such as microbial genomics and population studies of infectious disease epidemiology will enhance the resolution of the detection and monitoring of infectious disease outbreaks. The exponential growth in available microbial genomics data opens a unique opportunity to start 
